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p21a b s t r a c t
Post-translational modiﬁcation of forkhead family transcription factor, FoxO1, is an important
regulatory mode for its diverse activities. FoxO1 is acetylated by HAT coactivators and its
transcriptional activity is decreased via reduced DNA binding afﬁnity. Here, we report that SET/
TAF-Ib inhibited p300-mediated FoxO1 acetylation in an INHAT domain-dependent manner. SET/
TAF-Ib interacted with FoxO1 and activated transcription of FoxO1 target gene, p21. Moreover,
SET/TAF-Ib inhibited acetylation of FoxO1 and increased p21 transcription induced by oxidative
stress. Our results suggest that SET/TAF-Ib inhibits FoxO1 acetylation and activates its transcriptional
activity toward p21.
Structured summary of protein interactions:
FoxO1 physically interacts with SET/TAF-Ib by pull down (1, 2)
FoxO1 physically interacts with SET/TAF-Ib by anti tag coimmunoprecipitation (View interaction)
SET/TAF-Ib physically interacts with FoxO1 by anti bait coip (1, 2)
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction histone acetylation by p300/CBP and PCAF [10,11]. SET/TAF-IbThe FoxO family of forkhead transcription factors is evolution-
ally conserved and consists of the functionally related proteins
FoxO1 (FKHR), FoxO3a (FKHRL1), FoxO4 (AFX), and FoxO6 in mam-
mals [1,2]. Recent studies demonstrated that FoxO factors play key
roles in activation of various target genes, including metabolism,
cell cycle, cell death, DNA repair, and oxidative stress response
[2–5].
The transcriptional activity of FoxO1 is regulated by post-trans-
lational modiﬁcations and those modiﬁcations affect its subcellular
localization. FoxO1 is acetylated by p300, CBP (cAMP-response ele-
ment-binding protein), and PCAF (p300/CBP-associated factors) in
response to oxidative stress [6–8]. Acetylation of FoxO1 decreased
its transcriptional activity through attenuation of its DNA binding
ability [9]. FoxO1 is deacetylated by the sirtuin family member,
NAD-dependent deacetylase Sir2, which has a homolog in mam-
mals known as Sirt1, and resulted in increased transcriptional
activity [8].
We previously identiﬁed SET/TAF-Ib and pp32 as subunits of the
INHAT complex; binding of these proteins to histones preventsinhibits not only acetylation of histones but also acetylation of
non-histone proteins. We previously reported that SET/TAF-Ib reg-
ulates p53-mediated cell cycle arrest and apoptosis through inhibi-
tion of p53 acetylation [12]. Recently, we reported that inhibition
of Ku70 acetylation by SET/TAF-Ib regulates the Ku70-mediated
DNA damage response [13].
In the current study, we found that SET/TAF-Ib inhibits FoxO1
acetylation by p300 and increases its transcriptional activity. Fur-
thermore, SET/TAF-Ib inhibits the FoxO1 acetylation induced by
H2O2. We showed that SET/TAF-Ib regulates apoptosis through
inhibition of FoxO1 acetylation under oxidative stress conditions.
2. Materials and methods
2.1. Plasmid constructs
The pCMX-SET/TAF-Ib plasmid was previously described [11].
shRNA against human SET/TAF-Ib (RHS4533) was purchased from
OpenBiosystems. p3XFLAG-CMV10-SET/TAF-Ib, pCMX-FoxO1, p3X
FLAG-CMV10-FoxO1, p3XFLAG-CMV10-FoxO1D1 (1–240 aa), p3X
FLAG-CMV10-FoxO1D2 (236–440 aa), p3XFLAG-CMV10-FoxO1D3
(436–655 aa), pGEX4T1-FoxO1, pGEX4T1-FoxO1D1, pGEX4T1-
FoxO1D2, pGEX4T1-FoxO1D3, and pCMX-p300 were used.
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HEK293T cells were grown in Dulbecco’s modiﬁed Eagle’s med-
ium (DMEM), and HCT116 (p53/) cells and H1299 cells were
grown in RPMI 1640 containing 10% heat inactivated fetal bovine
serum and 0.05% penicillin–streptomycin at 37 C in a 5% CO2
atmosphere. HCT116 (p53/) cells and HEK293T cells were
transfected with the indicated DNA constructs using polyethyleni-
mine (PEI).
2.3. In vitro INHAT assay
INHAT assays were performed by incubating puriﬁed GST-SET/
TAF-Ib with GST-FoxO1 in HAT buffer [11] for 15 min on ice.
Following pre-incubation, p300, along with 14[C]-acetyl CoA
(10 lCi/ll, Perkin Elmer), were added for 2 h at 30 C. Reaction
products were separated by sodium dodecyl sulfate–polyacryl-
amide gel electrophoresis (SDS–PAGE) and analyzed by a phos-
phorimager. For scintillation counting, FoxO1 peptides [EGGK
SGKSPR] were synthesized (Peptron). Peptides were ﬁltered using
p81 ﬁlter paper (Upstate Biotechnology) and washed two times
with H3PO4 and one time with 95% ethanol. The ﬁlters were then
allowed to air dry, followed by the addition of 2 ml of Ultima Gold
(Perkin Elmer). 14[C]-acetyl CoA was then quantiﬁed using a scin-
tillation counter.
2.4. Immunoprecipitation
Immunoprecipitation was performed in order to investigate the
potential relationship between FoxO1 and SET/TAF-Ib interaction
and FoxO1 acetylation level. Cells were lysed in lysis buffer
(20 mM Tris–HCl [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1 mM EGTA,
1% Triton X-100, 1X protease inhibitor cocktail, and 1 mM PMSF) at
4 C. Proteins were immunoprecipitated with anti-FoxO1, anti-SET/
TAF-Ib or anti-Flag antibodies overnight at 4 C, and then protein
A/G agarose beads (GenDEPOT) were added for 2 h with rotation
at 4 C. Bound proteins were analyzed via western blotting with
anti-SET/TAF-Ib, anti-FoxO1, anti-Flag and anti-acetyl lysine antibodies.
2.5. Western blotting
Total protein extracts were prepared by lysing cells in radioim-
munoprecipitation assay (RIPA) lysis buffer (50 mM Tris–HCl [pH
8.0], 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate (SDC),
1% NP-40, 1X protease inhibitor cocktail, and 1 mM EDTA). Proteins
were resolved by SDS–PAGE and subsequently transferred to nitro-
cellulose membranes. Membranes were probed overnight with the
indicated antibodies at 4 C. Blots were subsequently incubated
with horseradish peroxidase (HRP)-conjugated anti-rabbit or
anti-mouse antibodies (Enzo Life Science), and bands were
detected using an enhanced chemiluminescence (ECL) system
(Animal Genetics Inc.).
2.6. Antibodies
Antibodies against FKHR (sc-374427), acetyl lysine (Ac-K) (sc-
32268), SET/TAF-Ib (sc-25564), H3 (sc-8654), b-actin (sc-47778),
His (sc-53073), p21 (sc-397; Santa Cruz Biotechnology), Flag
(F3165; SIGMA), Sirt1 (2496s; cell signaling), and caspase3 (04-
439; Upstate) were employed for western blotting and immuno-
precipitation (IP).
2.7. GST-pull down assay
Cell lysates from HEK293T cells ectopically expressing
Flag-FoxO1 were incubated with GST-SET/TAF-Ib or GST-SET/TAF-Ib deletion constructs. Likewise, GST-FoxO1, GST-FoxO1 dele-
tion constructs were incubated with SET/TAF-Ib-his overexpressed
cell lysates. Associated proteins were eluted, resolved by SDS–
PAGE, and immunoblotted with the indicated antibodies.
2.8. Reverse transcription and real-time PCR
Total RNA was isolated from transfected HCT116 (p53/) cells
using RNAiso Plus (TaKaRa). After cDNA synthesis, cDNA was
quantiﬁed and then subjected to p21 and FasL mRNA expression
analysis. The following PCR primers were used: p21 (forward,
50-GGCCCAGTGGACAGCGAGCA-30; reverse, 50-CCCAGGCGAAGTC
ACCCTCC-30), and FasL (forward, 50-ACACCTATGGAATTGTCCTG
C-30; reverse, 50-GACCAGAGAGAGCTCAGATACG-30). Disassociation
curves were performed after each PCR run to ensure that a single
product of the appropriate length was ampliﬁed. Mean threshold
cycle (CT) and standard error values were calculated from individ-
ual CT values obtained from triplicate reactions per stage. The nor-
malized mean CT value was estimated as DCT by subtracting the
mean CT of b-actin. The value DDCT was calculated as the differ-
ence between control DCT and values obtained for each sample.
The n-fold change in gene expression, relative to an untreated con-
trol, was calculated as 2DDCT .
2.9. Luciferase assay
Luciferase assays were conducted using a p21 promoter repor-
ter system. H1229 cells and HEK293T cells were co-transfected
with the p21 promoter reporter construct and the indicated DNA
constructs using Lipofectamine 2000 or PEI. After transfection, cells
were harvested and assayed for luciferase activity using a lucifer-
ase assay system (Promega). Each value was expressed as the mean
of ﬁve replicates from a single assay, and experiments were per-
formed at least three times.
2.10. Chromatin immunoprecipitation assay
HCT116 (p53/) cells were treated with H2O2 (500 lM) for
6 h. Cells were cross linked with 1% formaldehyde, which was
added to the medium for 10 min at RT, followed by the addition
of 125 mM glycine for 5 min at RT. Cells were then lysed in SDS
lysis buffer, after which samples were sonicated and immunopre-
cipitated using the indicated antibodies. Immunoprecipitates were
eluted and cross links were reversed; subsequently, DNA frag-
ments were puriﬁed using a PCR puriﬁcation kit (Axygen). The
following PCR primers were used: p21 (forward, 50-GTGGCTCTG
ATTGGCTTTCTG-30; reverse, 50-CTGAAAACAGGCAGCCCAAG-30).
Disassociation curves were generated after each PCR run to ensure
that a single product of the appropriate length was ampliﬁed. The
mean threshold cycle (CT) and standard error values were calcu-
lated from individual CT values, obtained from duplicate reactions
per stage. The normalized mean CT value was estimated as DCT by
subtracting the mean CT of the input from that of p21.
2.11. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) assay
HCT116 (p53/) cells were seeded in 48-well plates (2.5  104
cells/well) and transiently transfected with SET/TAF-Ib and shSET/
TAF-Ib. At 48 h post-transfection, cells were treated with 50 lM
H2O2 for 24 h. MTT was added to cells (20 lL, ﬁnal concentration
0.5 mg/mL), and cells were incubated a further 4 h at 37 C. At this
time, medium was removed by aspiration and DMSO was added
(200 lL). OD values were determined with an ELISA reader (Bio-
chrom) at a wavelength of 570 nm. The value of a blank sample,
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ues to correct for background in measurements.
2.12. BrdU incorporation assay
BrdU incorporation assays were performed according to the
manufacturer’s protocols (Roche Diagnostic). Brieﬂy, HCT116
(p53/) cells were seeded in 48-well plates (2.5  104 cells/well)
and subsequently transfected with either SET/TAF-Ib or shSET/
TAF-Ib. At 48 h post-transfection, cells were treated with H2O2
(50 lM) for 24 h. Cells were then incubated in BrdU-containing
medium for an additional 2 h, after which time absorbance was
measured at 370 nm (reference wavelength: 492 nm) with an
ELISA plate reader.
2.13. TUNEL assay
HCT116 (p53/) cells were seeded in 4-well chamber slides
and then transiently co-transfected with pCMX-SET/TAF-Ib and
shSET/TAF-Ib. After 2 days, cells were treated with 50 lM H2O2
for 24 h and subsequently ﬁxed with 4% paraformaldehyde for
1 h at RT. TUNEL (TdT-mediated dUTP nick end labeling) reactions
were then carried out using a DeadEndTM Fluorometric TUNEL
System, according to the manufacturer’s instructions (Promega).Fig. 1. SET/TAF-Ib inhibits acetylation of FoxO1. (A) Acetylation assays of FoxO1 with p3
of an INHAT assay using recombinant p300 with SET/TAF-Ib on GST-FoxO1D2 (top) f
represents the quantiﬁcation of FoxO1 acetylation. (B) FoxO1 peptides were used as subst
SET/TAF-IbD5. Acetylation levels were quantiﬁed via ﬁlter binding assay and were repres
HEK293T shSET/TAF-Ib stable cells (D) were transfected with indicated plasmids. After a
with anti-acetyl lysine, anti-FoxO1, and anti-SET/TAF-Ib antibodies. (E and F) HCT116 (p5
with indicated plasmids. After anti-Flag immunoprecipitation, eluted proteins were su
antibodies. Cells were treated with H2O2 (500 lM) for 6 h.3. Results
3.1. Inhibition of FoxO1 acetylation by SET/TAF-Ib
Previous studies found that FoxO1 can be acetylated at Lys-242,
Lys-246, and Lys-262 by PCAF, CBP, and p300 [6–8]. Such acetyla-
tion of FoxO1 attenuates its DNA binding ability and increases its
sensitivity to phosphorylation [9,14]. Our previous report demon-
strated that SET/TAF-Ib represses p53 activity through inhibition
of p53 acetylation [12]. Therefore, we hypothesized that SET/
TAF-Ib might inhibit acetylation of FoxO1. To investigate the regu-
lation of FoxO1 acetylation through INHAT activity of SET/TAF-Ib,
we ﬁrst tested whether SET/TAF-Ib can inhibit p300-mediated
FoxO1 acetylation using in vitro HAT assays. As expected, recombi-
nant p300 acetylated FoxO1, and FoxO1 acetylation was inhibited
by SET/TAF-Ib (Fig. 1A). To further conﬁrm the inhibition of FoxO1
acetylation by SET/TAF-Ib, we performed a HAT assay using 10-mer
FoxO1 peptides containing two acetylation target lysine residues
and measured acetylation levels by scintillation counting. Incuba-
tion of FoxO1 peptides including Lys-242 and Lys-246 with p300,
as well as SET/TAF-Ib signiﬁcantly decreased FoxO1 acetylation
(Fig. 1B). Moreover, SET/TAF-IbD3 and SET/TAF-IbD5 which have
deleted INHAT domain, did not change the FoxO1 acetylation level
(Fig. 1B). Inhibition of FoxO1 acetylation by SET/TAF-Ib was00 were performed with increasing concentrations of SET/TAF-Ib. An autoradiogram
ollowed by Coomassie staining (bottom). The number below the phosphorimage
rates in the INHAT assay with p300 with GST-SET/TAF-Ib, GST-SET/TAF-IbD3 or GST-
ented as raw counts per minute (cpm) incorporated. (C and D) HEK293T cells (C) and
nti-FoxO1 immunoprecipitation, eluted proteins were subjected to western blotting
3/) cells (E) and HCT116 (p53/) shSET/TAF-Ib stable cells (F) were transfected
bjected to Western blotting with anti-acetyl lysine, anti-Flag, and anti-SET/TAF-Ib
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HEK293T cells, the acetylation level of FoxO1 was increased. As
expected, overexpression of SET/TAF-Ib inhibited the FoxO1 acety-
lation level (Fig. 1C). However, the FoxO1 acetylation level was
clearly elevated in the shSET/TAF-Ib stable HEK293T cell line
(Fig. 1D). Two independent shSET/TAF-Ib RNAs have been tran-
siently expressed and showed increased FoxO1 acetylation levels
(Supplementary Fig. S1A). These results demonstrated that SET/
TAF-Ib inhibits FoxO1 acetylation in vitro and in vivo. Previous
studies reported that FoxO1 acetylation was increased under oxi-
dative stress [1,6,15,16]. Next, we tested whether SET/TAF-Ib can
inhibit FoxO1 acetylation in oxidative stress conditions. With exog-
enously overexpressed FoxO1, treatment with H2O2 resulted in a
high level of FoxO1 acetylation, while the FoxO1 acetylation level
was signiﬁcantly decreased when SET/TAF-Ib was overexpressed
(Fig. 1E). However, as expected, the FoxO1 acetylation level was
increased in the SET/TAF-Ib-knock-down cells (Fig. 1F). Again,
knock-down of SET/TAF-Ib by different shSET/TAF-Ib RNAs showedFig. 2. SET/TAF-Ib interaction with FoxO1 is mediated by its INHAT domain. (A) Cell lysat
SET/TAF-Ib, GST-SET/TAF-Ib deletion constructs. Associated proteins were eluted, resolve
length SET/TAF-Ib and SET/TAF-Ib deletion mutants were determined by Coomassie stai
pCMX-FoxO1, pCMX-SET/TAF-Ib, and pCMX-SET/TAF-IbD3 prior to immunoprecipitation
PAGE, and immunoblotted with the indicated antibodies. (C) SET/TAF-Ib was overexpress
FoxO1 deletion mutants as indicated. Associated proteins were eluted, resolved by SDS–P
and FoxO1 deletion constructs were determined by Coomassie staining. (D) HEK293T ce
deletion mutants thereof, and SET/TAF-Ib-his prior to immunoprecipitation with anti-Fla
SDS–PAGE, and immunoblotted with anti-Flag and anti-SET/TAF-Ib antibodies. (E) Endog
) cells treated with H2O2 (500 lM) for 6 h. Cell lysates were immunoprecipitated with
with anti-FoxO1 and anti-SET/TAF-Ib antibodies.the same results (Supplementary Fig. S1B). Therefore, these results
demonstrated that the oxidative stress-mediated FoxO1 acetyla-
tion level is regulated by SET/TAF-Ib.
3.2. Interaction between SET/TAF-Ib and FoxO1
Next, we tested whether SET/TAF-Ib interacts with FoxO1 by
in vitro binding assay with puriﬁed full length GST-SET/TAF-Ib, or
GST-SET/TAF-Ib deletion constructs incubated with lysate of
cells ectopically expressing FoxO1. Compared to GST-SET/TAF-Ib,
GST-SET/TAF-IbD3 and GST-SET/TAF-IbD5 which are C-terminal
INHAT domain deletion mutants did not interact with FoxO1
(Fig. 2A). We also conﬁrmed this interaction in vivo by IP with
anti-SET/TAF-Ib antibodies. As predicted, FoxO1 interacted with
the INHAT domain of SET/TAF-Ib (Fig. 2B). However, a weak inter-
action between SET/TAF-IbD3 and FoxO1 was also observed, prob-
ably due to the presence of endogenous SET/TAF-Ib in the lysates.
The results of this experiment indicated that FoxO1 interaction ises from HEK293T cells ectopically expressing Flag-FoxO1 were incubated with GST-
d by SDS–PAGE, and immunoblotted with anti-Flag antibodies. The amounts of full-
ning. (B) HEK293T cells were transfected with constructs driving the expression of
with anti-SET/TAF-Ib antibodies. Associated proteins were eluted, resolved by SDS–
ed in HEK293T cells prior to cell lysis and pull-down assays with immobilized GST-
AGE, and immunoblotted with anti-his antibodies. The amounts of full-length FoxO1
lls were transfected with plasmids driving the expression of full-length Flag-FoxO1,
g antibodies. Immunoprecipitated and associated proteins were eluted, resolved by
enous interaction between SET/TAF-Ib and FoxO1 were examined in HCT116 (p53/
anti-FoxO1 antibodies and associated proteins were analyzed by Western blotting
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interaction using FoxO1 deletion constructs, too. To reveal the
FoxO1 interaction site with SET/TAF-Ib, we performed a GST-pull
down assay with puriﬁed GST-FoxO1 deletion mutants. SET/TAF-
Ib can inhibit acetylation through interaction with the acetylation
site of the target protein. Thus, we hypothesized that SET/TAF-Ib
may bind to FoxO1 acetylation sites. We observed that FoxO1D2,
including Lys-242 and Lys-246, bound to SET/TAF-Ib (Fig. 2C). This
interaction was conﬁrmed by showing an interaction betweenFig. 3. SET/TAF-Ib regulates FoxO1 target genes. (A and B) SET/TAF-Ib-his transfected HC
by real time PCR to examine the mRNA expression levels of p21 (A) and FasL (B). Cells wer
⁄⁄⁄P < 0.001; ⁄⁄P < 0.01. (C and D) Protein expression levels of p21 were examined by Wes
shSET/TAF-Ib stable HCT116 (p53/) cells (D). Cells were treated with H2O2 (500 lM) fo
the p21 promoter-luc construct and either pCMX, pCMX-FoxO1, pCMX-p300, pCMX-SE
luciferase activity. Luciferase activities were normalized to those of b-galactosidase. Res
(p53/) cells and HCT116 (p53/) shSET/TAF-Ib stable cells were treated with H2O2
TAF-Ib antibodies. Recruitment of FoxO1 and SET/TAF-Ib to the p21 promoter region was
Results are shown as means ± SDs; n = 3. ⁄⁄⁄P < 0.001; ⁄P < 0.05.FoxO1 constructs and SET/TAF-Ib by IP in vivo (Fig. 2D). Likewise,
SET/TAF-Ib was found to bind to FoxO1D2 in vivo. To further con-
ﬁrm the interactions, we showed that endogenous SET/TAF-Ib
interacts with FoxO1 in HCT116 (p53/) cells in the absence of
H2O2 treatment (Fig. 2E). Next, we tested interaction between
SET/TAF-Ib and FoxO1-3KA (K242A, K245A, K262A) mutant which
acetylation site lysines are substituted with alanines. The muta-
tions on these acetylation sites did not inﬂuence interaction
between FoxO1 and SET/TAF-Ib (Supplementary Fig. S3). These dataT116 (p53/) cells and shSET/TAF-Ib stable HCT116 (p53/) cells were analyzed
e treated with H2O2 (500 lM) for 6 h or not. Results are shown as means ± SDs; n = 3.
tern blotting in HCT116 (p53/) cells via pCMX-SET/TAF-Ib overexpression (C) and
r 6 h or not. (E and F) H1299 cells (E) and HEK293T cells (F) were co-transfected with
T/TAF-Ib, shSET/TAF-Ib#1, or shSET/TAF-Ib#2. Cell extracts were then assayed for
ults are shown as means ± SDs; n = 3. ⁄⁄⁄P < 0.001; ⁄⁄P < 0.01; ⁄P < 0.05. (G) HCT116
(500 lM) for 6 h. ChIP analysis was then conducted using anti-FoxO1 and anti-SET/
normalized to the assay inputs. Anti-IgG antibodies were used as a negative control.
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interaction with FoxO1 acetylation sites. We performed Sirt1 and
FoxO1 interaction assay and conﬁrmed that SET/TAF-Ib did not
affect the interaction (Supplementary Fig. S2).
3.3. FoxO1 target genes were regulated by SET/TAF-Ib
A previous study found that acetylation of FoxO1 decreased its
transcriptional activity through attenuation of its DNA binding
ability [9]. Therefore, we hypothesized that SET/TAF-Ib increases
the transcriptional activity of FoxO1 via inhibition of FoxO1 acety-
lation. To conﬁrm this hypothesis, we conducted real-time PCR. We
treated HCT116 (p53/) cells with different concentrations of
H2O2 to induce FoxO1 acetylation in cells that were either over-
expressing SET/TAF-Ib or had been subjected to knock-down of
SET/TAF-Ib. The FoxO1 target gene, p21, was down-regulated via
induction of FoxO1 acetylation by H2O2 treatment. However, the
transcriptional level of p21 was increased when SET/TAF-Ib was
overexpressed (Fig. 3A and Supplementary Fig. S4A). In contrast,
FoxO1 transcriptional activity was decreased when shSET/TAF-Ib
stable cell line was used (Fig. 3A and Supplementary Fig. S4B).
We tested additional FoxO1 target genes including FasL, PUMA,
and Bim and found FasL showed prominent change in expression
similar to that of p21 (Fig. 3B). To further conﬁrm the regulationFig. 4. SET/TAF-Ib promotes apoptosis in oxidative stress conditions. (A and B) HCT116 (
plasmids. Each cell lysate was resolved by SDS–PAGE and immunoblotted with anti-FoxO
determined by MTT assay. HCT116 (p53/) cells were treated with H2O2 (50 lM) for 24
n = 3. ⁄⁄⁄P < 0.001; ⁄⁄P < 0.01. (D) HCT116 (p53/) cells were transfected with the indi
cells were ﬁxed and BrdU assays performed. Results are shown as means ± SDs; n = 3.
constructs upon H2O2 (50 lM) for 24 h were subjected to TUNEL assays. DNase I-treateof FoxO1 target genes, we tested whether SET/TAF-Ib regulates
the FoxO1 target gene on the protein level. We observed the
increase in protein level of p21 via SET/TAF-Ib mediated the
inhibition of FoxO1 acetylation despite H2O2 treatment (Fig. 3C).
In contrast, when SET/TAF-Ib was knocked down, p21 was
decreased (Fig. 3D). Subcellular localization of FoxO1 remained
unaltered both in SET/TAF-Ib overexpression and knock-down cells
(Supplementary Fig. S5A and B). To further conﬁrm these results,
we performed a reporter assay using a p21 promoter-driven
luciferase (luc) reporter system in different cell lines. In reporter
assays performed in exogenous FoxO1-expressing H1299 and
HEK293T cell lines, SET/TAF-Ib increased p21 promoter activity.
On the other hand, p21 promoter activity was decreased when
SET/TAF-Ib was knocked down (Fig. 3E and F). To determine if
FoxO1 transcriptional activity was increased by SET/TAF-Ib, we
conducted a chromatin immnoprecipitation (ChIP) assay. When
SET/TAF-Ib was knocked down, recruitment of FoxO1 on the p21
promoter was reduced. In comparison with the untreated
condition, recruitment of FoxO1 on the p21 promoter was further
decreased under oxidative stress (Fig. 3G). Recruitment of
SET/TAF-Ib to p21 promoter was downregulated by H2O2 treatment
similar to those of FoxO1 (Fig. 3G). All together, these data demon-
strated that SET/TAF-Ib regulates transcriptional activity of FoxO1
through inhibition of FoxO1 acetylation.p53/) cells (A) and shSET/TAF-Ib stable cells (B) were transfected with indicated
1, anti-SET/TAF-Ib, anti-caspase3, and anti-b-actin antibodies. (C) Cell viability was
h and transfected with the indicated constructs. Results are shown as means ± SDs;
cated constructs upon H2O2 (50 lM) incubation for 24 h. At 72 h post-transfection,
⁄⁄⁄P < 0.001. (E) HCT116 (p53/) cells, transiently transfected with the indicated
d cells are shown as a positive control.
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Previous studies revealed that H2O2 induced apoptosis through
activation of caspase 3 and caspase 9 [17,18]. To further investigate
the biological role of SET/TAF-Ib in the cellular functions of FoxO1,
we measured the apoptosis-inducing protein, caspase 3. When
FoxO1 acetylation was reduced by SET/TAF-Ib, apoptosis was fur-
ther up-regulated (Fig. 4A). In contrast, when SET/TAF-Ib was
knocked down, apoptosis was reduced via increasing FoxO1 acety-
lation (Fig. 4B). To conﬁrm the regulation of apoptosis by FoxO1
acetylation level, we performed an MTT assay to measure cell
survival via treatment of H2O2. As shown in Fig. 4C, cell survival
was reduced when acetylation of FoxO1 was decreased, and cell
survival was increased when SET/TAF-Ib was knocked down
(Fig. 4C). Consistent results were obtained in BrdU analysis, in
which decreasing of FoxO1 acetylation by SET/TAF-Ib decreased
cell viability and knock-down of SET/TAF-Ib increased cell viability
(Fig. 4D). Positive regulation of apoptosis by SET/TAF-Ib was also
investigated by TUNEL assay. The amount of apoptotic nuclei in
DNase I-treated control and H2O2 treated cells decreased upon
knock-down of SET/TAF-Ib by different two shRNA sequences, a
ﬁnding which supports the hypothesis that reducing of FoxO1
acetylation by SET/TAF-Ib positively regulates apoptosis (Fig. 4E).
Altogether, our study demonstrated that decreasing FoxO1 acetyla-
tion by SET/TAF-Ib regulates the transcriptional activity of FoxO1
and these mechanisms are able to regulate apoptosis under oxida-
tive stress.
4. Discussion
FoxO1 regulates cell survival and apoptosis via regulation of its
target genes such as Bim, PUMA, and p21 [19]. Regulation of
FoxO1-mediated apoptosis and cell survival are important to
FoxO1 acetylation status. Here, we tried to elucidate the correla-
tion of FoxO1 and the INHAT complex subunit SET/TAF-Ib in
human cells. We found that SET/TAF-Ib inhibits FoxO1 acetylation
by p300. We demonstrated that SET/TAF-Ib regulates the transcrip-
tional activity of FoxO1 through regulation of FoxO1 acetylation.
Furthermore, our results suggest that reducing FoxO1 acetylation
by SET/TAF-Ib regulates FoxO1-mediated apoptosis in oxidative
stress conditions. Acetylated FoxO1 not only showed attenuated
DNA binding ability but was also more sensitive to phosphoryla-
tion [9]. Phosphorylation of FoxO1 led to its translocation from
the nucleus to the cytoplasm [20,21]. Domain mapping analysis
indicated that SET/TAF-Ib inhibits FoxO1 acetylation through
masking of its acetylation site and increases recruitment of FoxO1
on the p21 promoter. In oxidative stress conditions, acetylation of
FoxO1 was increased by CBP/p300. It is intriguing that SET/TAF-Ib
inhibits acetylation of FoxO1 under oxidative stress. Among FoxO1
target genes, p21 transcription was increased via inhibition of
FoxO1 acetylation. In oxidative stress conditions, recruitment
of FoxO1 on the p21 promoter is reduced through the induction
of FoxO1 acetylation. However, when SET/TAF-Ib was overexpres-
sed, recruitment of FoxO1 to the p21 promoter was increased. In
addition, we showed that FoxO1-mediated apoptosis is increased
via inhibition of FoxO1 acetylation by SET/TAF-Ib. As a result,
SET/TAF-Ib is able to regulate FoxO1 transcriptional activity under
oxidative stress.
In conclusion, our data provide evidence that SET/TAF-Ib nega-
tively regulates FoxO1 acetylation. Inhibition of FoxO1 acetylation
by SET/TAF-Ib induces transcription of the FoxO1 target gene, p21.
Moreover, these studies indicate that inhibition of FoxO1 acetyla-
tion by SET/TAF-Ib regulates aspects of cellular physiology such
as apoptosis and cell survival via p21 regulation.Acknowledgments
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